Goldstein, Alisa M.
National Cancer Institute (NCI),
United States
2025 Rank: 36609
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1611 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36609 | 34032 |
| Total Cites | 23533 | 27606 |
| H-index | 74 | 84 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 115 | 131 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2506 | 3053 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 3732 | 4438 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17497 | 19045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.45 |
| Self-Citation Percentage |
14.75%
|
|
Goldstein, Alisa M.
National Cancer Institute (NCI),
United States
2024 Rank: 35569
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1599 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35569 | 33293 |
| Total Cites | 22353 | 26270 |
| H-index | 73 | 81 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 106 | 122 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2393 | 2923 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 3517 | 4196 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16599 | 18073 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.45 |
| Self-Citation Percentage |
14.91%
|
|
Goldstein, Alisa M.
National Cancer Institute (NCI),
United States
2023 Rank: 35874
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1624 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35874 | 33111 |
| Total Cites | 21018 | 24795 |
| H-index | 68 | 78 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 100 | 116 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 2313 | 2836 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 3353 | 4017 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15570 | 16974 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.46 |
| Self-Citation Percentage |
15.23%
|
|
Goldstein, Alisa M.
National Cancer Institute (NCI),
United States
2022 Rank: 34974
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1585 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34974 | 31456 |
| Total Cites | 19585 | 23113 |
| H-index | 64 | 74 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 98 | 114 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 2198 | 2702 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 3156 | 3790 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14422 | 15743 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.47 |
| Self-Citation Percentage |
15.26%
|
|
Goldstein, Alisa M.
National Cancer Institute (NCI),
United States
2021 Rank: 34723
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1576 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34723 | 31913 |
| Total Cites | 18778 | 22170 |
| H-index | 64 | 73 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 94 | 109 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 2063 | 2548 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 2967 | 3575 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13848 | 15126 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.47 |
| Self-Citation Percentage |
15.30%
|
|
Goldstein, Alisa M.
National Cancer Institute,
United States
2020 Rank: 34699
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1649 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34699 | 31459 |
| Total Cites | 17213 | 20356 |
| H-index | 59 | 69 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 86 | 101 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1946 | 2410 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 2773 | 3347 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12619 | 13806 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.47 |
| Self-Citation Percentage |
15.44%
|
|